Freestone Capital Holdings’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.11M | Buy |
26,923
+1,634
| +6% | +$132K | 0.05% | 196 |
|
|
2026
Q1 | $2.19M | Buy |
25,289
+123
| +0.5% | +$11.8K | 0.07% | 172 |
|
|
2025
Q4 | $2.42M | Buy |
25,166
+996
| +4% | +$96.7K | 0.07% | 164 |
|
|
2025
Q3 | $2.3M | Buy |
24,170
+162
| +0.7% | +$14.9K | 0.07% | 166 |
|
|
2025
Q2 | $2.09M | Sell |
24,008
-1,176
| -5% | -$99.7K | 0.07% | 162 |
|
|
2025
Q1 | $2.26M | Sell |
25,184
-101
| -0.4% | -$9.04K | 0.08% | 152 |
|
|
2024
Q4 | $2.02M | Sell |
25,285
-573
| -2% | -$49.6K | 0.07% | 159 |
|
|
2024
Q3 | $2.33M | Sell |
25,858
-765
| -3% | -$64.4K | 0.08% | 154 |
|
|
2024
Q2 | $2.1M | Buy |
26,623
+2,273
| +9% | +$186K | 0.07% | 161 |
|
|
2024
Q1 | $2.12M | Buy |
24,350
+708
| +3% | +$60.4K | 0.08% | 163 |
|
|
2023
Q4 | $1.95M | Sell |
23,642
-19,344
| -45% | -$1.47M | 0.09% | 158 |
|
|
2023
Q3 | $3.37M | Buy |
42,986
+13,730
| +47% | +$1.15M | 0.18% | 102 |
|
|
2023
Q2 | $2.58M | Sell |
29,256
-601
| -2% | -$51.7K | 0.1% | 135 |
|
|
2023
Q1 | $2.41M | Sell |
29,857
-2,043
| -6% | -$167K | 0.11% | 128 |
|
|
2022
Q4 | $2.48M | Sell |
31,900
-2,534
| -7% | -$205K | 0.11% | 127 |
|
|
2022
Q3 | $2.78M | Sell |
34,434
-4,919
| -12% | -$442K | 0.13% | 115 |
|
|
2022
Q2 | $3.53M | Sell |
39,353
-13,691
| -26% | -$1.39M | 0.13% | 105 |
|
|
2022
Q1 | $5.88M | Buy |
53,044
+619
| +1% | +$65.4K | 0.24% | 89 |
|
|
2021
Q4 | $5.42M | Sell |
52,425
-1,402
| -3% | -$162K | 0.23% | 96 |
|
|
2021
Q3 | $6.75M | Sell |
53,827
-8,149
| -13% | -$1.05M | 0.34% | 72 |
|
|
2021
Q2 | $7.69M | Buy |
61,976
+82
| +0.1% | +$10.3K | 0.39% | 61 |
|
|
2021
Q1 | $7.31M | Sell |
61,894
-4,242
| -6% | -$497K | 0.4% | 66 |
|
|
2020
Q4 | $7.75M | Buy |
66,136
+10,949
| +20% | +$1.21M | 0.45% | 51 |
|
|
2020
Q3 | $5.74M | Sell |
55,187
-1,973
| -3% | -$198K | 0.37% | 66 |
|
|
2020
Q2 | $5.24K | Sell |
57,160
-4,790
| -8% | -$459K | 0.06% | 72 |
|
|
2020
Q1 | $5.59K | Buy |
61,950
+5,401
| +10% | +$575K | 0.12% | 61 |
|
|
2019
Q4 | $6.42K | Buy |
56,549
+14,496
| +34% | +$1.59M | 0.13% | 54 |
|
|
2019
Q3 | $4.57K | Buy |
42,053
+9,993
| +31% | +$1.04M | 0.11% | 84 |
|
|
2019
Q2 | $3.12K | Buy |
32,060
+3,421
| +12% | +$312K | 0.08% | 135 |
|
|
2019
Q1 | $2.61M | Buy |
28,639
+1,902
| +7% | +$170K | 0.15% | 148 |
|
|
2018
Q4 | $2.43M | Buy |
26,737
+5,211
| +24% | +$487K | 0.16% | 146 |
|
|
2018
Q3 | $2.12M | Buy |
21,526
+2,565
| +14% | +$237K | 0.01% | 165 |
|
|
2018
Q2 | $1.62M | Buy |
18,961
+1,495
| +9% | +$125K | 0.01% | 176 |
|
|
2018
Q1 | $1.4M | Buy |
17,466
+209
| +1% | +$17.2K | 0.08% | 181 |
|
|
2017
Q4 | $1.39M | Sell |
17,257
-3,109
| -15% | -$249K | 0.1% | 180 |
|
|
2017
Q3 | $1.58M | Buy |
20,366
+1,409
| +7% | +$117K | 0.11% | 154 |
|
|
2017
Q2 | $1.68M | Buy |
18,957
+10,599
| +127% | +$894K | 0.13% | 149 |
|
|
2017
Q1 | $673K | Buy |
+8,358
| New | +$653K | 0.05% | 233 |
|
|
2016
Q4 | – | Sell |
-2,906
| Closed | -$251K | – | 358 |
|
|
2016
Q3 | $251K | Sell |
2,906
-189
| -6% | -$16.5K | 0.02% | 312 |
|
|
2016
Q2 | $269K | Sell |
3,095
-145
| -4% | -$11.7K | 0.03% | 296 |
|
|
2016
Q1 | $243K | Buy |
3,240
+67
| +2% | +$5.05K | 0.03% | 303 |
|
|
2015
Q4 | $244K | Buy |
+3,173
| New | +$239K | 0.03% | 316 |
|
Other funds holding MDT
MGP
Freestone Capital Holdings's MDT Position: Q2 2026 in Review
Freestone Capital Holdings increased its Medtronic (MDT) stake by 6.5% in Q2 2026, buying an estimated $132K and bringing the position to 26,923 shares worth $2.11M. The position accounts for 0.05% of the portfolio, ranked #196.
Freestone Capital Holdings first reported a position in MDT in Q4 2015 and has held it in 42 quarters since. The position peaked at $7.75M in Q4 2020. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Freestone Capital Holdings held 26,923 shares of Medtronic worth $2.11M as of Q2 2026.
- Freestone Capital Holdings bought 1,634 Medtronic shares in Q2 2026, an estimated $132K.
- Medtronic made up 0.05% of Freestone Capital Holdings's portfolio in Q2 2026, its #196 holding.
- Freestone Capital Holdings first reported a position in Medtronic in Q4 2015 and has held it in 42 quarters since.
- Freestone Capital Holdings's Medtronic position peaked at $7.75M in Q4 2020.
- 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.